Charlie Sheen emerges as an indica-dominant hybrid with a substantial indica backbone and a hint of sativa lift. Its lineage blends OG Kush with Green Crack and Blue Dream, three legendary strains whose potency is well documented. THC tests commonly top 23 percent, while CBD hovers above one percent, making it a compelling option for medical patients seeking relief without sacrificing potency. Also known as Charlie Sheen OG, the cultivar is typically described as roughly seventy percent indica and thirty percent sativa, a ratio that informs its balanced, deeply relaxing body feel with a hint of cerebral clarity.
Users report a dual-edged experience: physical ease paired with an upbeat, energizing mental state. The effects can evoke euphoria, happiness, and sociability, with a touch of focus that helps conversation and activity. Therapeutically, many patients turn to it for anxiety, depression, chronic pain, fatigue, insomnia, loss of appetite, migraines, and PTSD, while others find it helpful in managing stress and arthritis.
The aroma blends cotton candy sweetness with earthy Kush notes, and the flavor carries berry, lemon, pine, and a sweet, grassy undertone. In practice, the cannabis tends to carry a potent sensory profile, and users may encounter paranoia as the most common adverse effect, along with dry mouth and red eyes. Availability centers in West Coast and nearby states such as California, Arizona, and Washington, reflecting its popularity as a medical choice alongside its enduring street and garden appeal.